ATE399159T1 - Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung - Google Patents
Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterungInfo
- Publication number
- ATE399159T1 ATE399159T1 AT05802359T AT05802359T ATE399159T1 AT E399159 T1 ATE399159 T1 AT E399159T1 AT 05802359 T AT05802359 T AT 05802359T AT 05802359 T AT05802359 T AT 05802359T AT E399159 T1 ATE399159 T1 AT E399159T1
- Authority
- AT
- Austria
- Prior art keywords
- silanesters
- silaneamids
- oxothiazolidine
- preventing
- carbonic acid
- Prior art date
Links
- 230000009759 skin aging Effects 0.000 title 1
- -1 Thiazolidine derivative compound Chemical class 0.000 abstract 2
- 125000005257 alkyl acyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0452399A FR2877004B1 (fr) | 2004-10-21 | 2004-10-21 | Esters et amides silaniques d'acide 2-oxothiazolidine-4- carboxylique et leurs utilisations cosmetiques. |
| US63254104P | 2004-12-03 | 2004-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE399159T1 true ATE399159T1 (de) | 2008-07-15 |
Family
ID=34950806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05802359T ATE399159T1 (de) | 2004-10-21 | 2005-09-27 | Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7795286B2 (https=) |
| EP (1) | EP1805153B1 (https=) |
| JP (1) | JP5149011B2 (https=) |
| AT (1) | ATE399159T1 (https=) |
| DE (1) | DE602005007764D1 (https=) |
| ES (1) | ES2308565T3 (https=) |
| FR (1) | FR2877004B1 (https=) |
| WO (1) | WO2006045639A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2731298T3 (es) | 2005-05-27 | 2019-11-14 | Univ North Carolina Chapel Hill | Partículas de liberación de óxido nítrico para agentes terapéuticos de óxido nítrico y aplicaciones biomédicas |
| EP1968609A4 (en) * | 2005-12-20 | 2010-06-09 | Silamed Inc | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE USE OF HIGHLY LIPOPHILIC SULFHYDRYL COMPOUNDS |
| FR2921257B1 (fr) * | 2007-09-21 | 2009-11-06 | Exsymol Sa | Utilisation topique de derives thiazolidines contre les consequences du stress oxydatif de la peau |
| FR2940615B1 (fr) | 2008-12-30 | 2011-12-30 | Oreal | Association de monosaccharides avec des agents antioxydants et son utilisation en cosmetique |
| CA2771389C (en) | 2009-08-21 | 2019-04-09 | Novan, Inc. | Wound dressings, methods of using the same and methods of forming the same |
| WO2011022652A1 (en) | 2009-08-21 | 2011-02-24 | Novan, Inc. | Topical gels |
| AU2011227198A1 (en) * | 2010-03-17 | 2012-10-04 | Arbonne International Llc | Topical skin care composition |
| US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
| WO2012118829A2 (en) | 2011-02-28 | 2012-09-07 | Novan, Inc. | Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same |
| US9132725B2 (en) | 2011-05-09 | 2015-09-15 | Cummins Inc. | Vehicle and hybrid drive system |
| US10239847B1 (en) | 2016-03-03 | 2019-03-26 | Cellactin | Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione |
| JP7118591B2 (ja) | 2017-02-28 | 2022-08-16 | ロレアル | レゾルシノール又はその誘導体を含む組成物 |
| JP7412898B2 (ja) | 2019-04-26 | 2024-01-15 | ロレアル | 特異な粒子と親油性抗酸化剤との組み合わせ |
| JP7612326B2 (ja) | 2019-12-16 | 2025-01-14 | ロレアル | 特定の成分の組合せを含む安定な組成物 |
| WO2023120259A1 (en) | 2021-12-20 | 2023-06-29 | Oreal | Stable composition comprising retinoid |
| FR3131837B1 (fr) | 2022-01-19 | 2024-10-04 | Oreal | Composition stable comprenant un rétinoïde et un composé acide ascorbique |
| FR3131845B1 (fr) | 2022-01-19 | 2024-11-01 | Oreal | Composition stable comprenant un rétinoïde |
| EP4452190A1 (en) | 2021-12-20 | 2024-10-30 | L'oreal | Stable composition comprising retinoid and ascorbic acid compound |
| EP4637675A1 (en) | 2022-12-20 | 2025-10-29 | L'oreal | Composition comprising hyaluronic acid-based polyion complex and hydrophilic or lipophilic antioxidant |
| FR3145279B1 (fr) | 2023-01-30 | 2026-01-30 | Oreal | Composition comprenant un complexe polyionique à base d’acide hyaluronique et un antioxydant lipophile |
| WO2024135577A1 (en) | 2022-12-23 | 2024-06-27 | L'oreal | Stable dispersion composition comprising retinoid |
| FR3145278B1 (fr) | 2023-01-30 | 2026-04-10 | Oreal | Composition de dispersion stable comprenant un rétinoïde |
| FR3148912B1 (fr) | 2023-05-24 | 2026-02-20 | Oreal | Composition comprenant des polymères cationiques et anioniques |
| FR3152226B3 (fr) | 2023-08-25 | 2025-09-19 | Oreal | Composition cosmétique anhydre pour une application douce et peu grasse |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5208249A (en) * | 1992-08-20 | 1993-05-04 | Clintec Nutrition Co. | Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate |
| FR2854160B1 (fr) * | 2003-04-25 | 2005-06-17 | Oreal | Nouveaux derives heterocycliques de l'acide 2-oxothiazolidine4-carboxylique, utilisation comme agent de photoprotection active |
-
2004
- 2004-10-21 FR FR0452399A patent/FR2877004B1/fr not_active Expired - Fee Related
-
2005
- 2005-09-27 WO PCT/EP2005/012032 patent/WO2006045639A1/en not_active Ceased
- 2005-09-27 ES ES05802359T patent/ES2308565T3/es active Active
- 2005-09-27 DE DE602005007764T patent/DE602005007764D1/de active Active
- 2005-09-27 EP EP05802359A patent/EP1805153B1/en not_active Not-in-force
- 2005-09-27 AT AT05802359T patent/ATE399159T1/de not_active IP Right Cessation
- 2005-09-27 JP JP2007537238A patent/JP5149011B2/ja not_active Expired - Fee Related
- 2005-09-27 US US11/577,600 patent/US7795286B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2308565T3 (es) | 2008-12-01 |
| FR2877004A1 (fr) | 2006-04-28 |
| US7795286B2 (en) | 2010-09-14 |
| EP1805153A1 (en) | 2007-07-11 |
| EP1805153B1 (en) | 2008-06-25 |
| FR2877004B1 (fr) | 2007-03-09 |
| JP5149011B2 (ja) | 2013-02-20 |
| US20090074682A1 (en) | 2009-03-19 |
| JP2008517030A (ja) | 2008-05-22 |
| WO2006045639A1 (en) | 2006-05-04 |
| DE602005007764D1 (de) | 2008-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE399159T1 (de) | Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung | |
| AR038379A1 (es) | Esteres de acidos fluoreno-carboxilicos, procedimientos para su preparacion asi como su utilizacion en calidad de medicamentos | |
| CO5611113A2 (es) | Tripeptidos que poseen un eter de hidroxiprolina de una quinolina sustituida para la inhibicion de ns3 (hepatitis c) | |
| ECSP034524A (es) | Derivados de pirina con actividad inhibidora de quinasa ikb (ikk-beta) | |
| DE10190550D2 (de) | Kosmetische Zusammensetzung | |
| DE602004005886D1 (de) | Derivate von n-äphenyl(alkylpiperidin-2-yl)methylübenzamid, verfahren zu deren herstellung und deren anwendung in therapeutika | |
| ATE461259T1 (de) | Flüssigkristallines medium mit monofluor- terphenylverbindungen | |
| EA200500146A1 (ru) | Моноэтансульфонат 3-z-[1-4-(n-((4-метилпиперазин-1-ил)метилкарбонил)-n-метиламино)анилино)-1-фенилметилен]-6-метоксикарбонил-2-индолинона и его применение в составе фармацевтической композиции | |
| ATE260272T1 (de) | Beta-aminsäure-derivate zur verwendung als matrix-metalloproteasen- und tna-alpha-inhibitoren | |
| MX2009006598A (es) | Derivados de sulfamida como transferasa de carnitina palmitoil del higado (l-cptl). | |
| CY1109737T1 (el) | Νεα μεθοδος συνθεσης του (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγομελατινης | |
| ATE377420T1 (de) | Phenylalkansäure- und phenyloxyalkansäure- derivate als hppar aktivatore | |
| MA31346B1 (fr) | Formulation liquide injectable de paracetamol | |
| TR200301248A2 (tr) | Antibiyotik Aktiviteye Sahip Olan Farmasotik Kompozisyonlar. | |
| DOP2006000045A (es) | Derivados del (1,5-difenil-1h-pirazol-3-il oxadiazol, su preparacion y su aplicacion en terapeutica | |
| ATE88697T1 (de) | E-isomere von n alpha-(2-cyan-2-alkoximinoacetyl)-amino-s|urederivaten und -peptiden. | |
| CY1110613T1 (el) | Υποκατεστημενες θειαζολες και η χρησιμοποιηση τους για την παρασκευη φαρμακων | |
| ECSP099339A (es) | Derivados de pirrol, su preparación y su utilización en terapéutica | |
| NO20070832L (no) | Farmasoytiske preparat av piperazinderivater. | |
| BRPI0912551A8 (pt) | Compostos para tingimento de queratina, composições para tingimento de queratina contendo os ditos compopstos, e uso dos mesmos | |
| DE60307891D1 (de) | Verwendung eines akariziden pulvers | |
| ATE493110T1 (de) | Kosmetische zusammensetzung zur stimulierung der synthese der proteine der basalmembran | |
| CR8748A (es) | Una composicion farmaceutica antimicobacteriana | |
| DOP2006000133A (es) | Derivados de 4,5 diarilpiroxol, su preparación y su aplicación en terapeútica | |
| ME00059B (me) | Oksidekahidronaftalen modulatori hm74 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |